Figura Suplementaria 2 de la Distribución Diferencial del Inhibidor de DNA-PKcs Peposertib que Radiosensibiliza Selectivamente Xenoinjertos de Metástasis Cerebrales de Melanoma Derivados de Pacientes

Ji et al. (mié,) estudiaron esta cuestión.

www.synapsesocial.com/papers/68e5778bb6db6435875173ee — DOI: https://doi.org/10.1158/1535-7163.27102352.v1

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Supplementary Figure 2 from Differential Distribution of the DNA-PKcs Inhibitor Peposertib Selectively Radiosensitizes Patient-derived Melanoma Brain Metastasis Xenografts· 2024
2. Supplementary Figure 2 from Differential Distribution of the DNA-PKcs Inhibitor Peposertib Selectively Radiosensitizes Patient-derived Melanoma Brain Metastasis Xenografts· 2024
3. Supplementary Figure 2 from Differential Distribution of the DNA-PKcs Inhibitor Peposertib Selectively Radiosensitizes Patient-derived Melanoma Brain Metastasis Xenografts· 2024
4. Supplementary Figure 1 from Differential Distribution of the DNA-PKcs Inhibitor Peposertib Selectively Radiosensitizes Patient-derived Melanoma Brain Metastasis Xenografts· 2024
5. Supplementary Figure 1 from Differential Distribution of the DNA-PKcs Inhibitor Peposertib Selectively Radiosensitizes Patient-derived Melanoma Brain Metastasis Xenografts· 2024